AMD: First Quarter Analyst Consensus Estimates

Advanced Micro Devices (NASDAQ: AMD) will be reporting their first quarter financial results on April 27th after market close. Analysts have a consensus $102.50 12-month price target on the company, via a total of 39 analysts, with six analysts having strong buy ratings. 18 analysts meanwhile have buy ratings, 13 have hold ratings, 1 analyst has a sell rating and 1 has a strong sell rating on the company. The street high comes from Elazar Advisors with a $161.90 price target, and the lowest target sits at $59 from Clevelland Research.

29 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 29 analysts is $3.22 billion; this number has been revised upwards from $2.73 billion at the start of the year. The highest revenue estimate is $3.3 billion, while the lowest is $3.1 billion.

Onto EBITDA estimates, there are currently only 8 analysts who have first-quarter EBITDA estimates. The mean is currently $718.9 million, with this number having been revised upwards from $519.11 million at the start of the year. The street high estimate currently sits at $739.2 million in EBITDA and the lowest is $651.5 million.

Analysts estimate that quarterly earnings per share will come in at $0.45, with this number being slightly revised upwards from $0.35 at the start of the year. Street high is $0.48 and the lowest estimate is $0.35 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

G Mining Q3 Earnings: Costs Down, Production Up

Endeavour Silver Q3 Earnings: On The Upswing

Recommended

Kalshi Faces Class Action Lawsuit Over Alleged Illegal Sports Betting

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Related News

Trillion Energy: Research Capital Initiates Coverage With $1.35 Price Target

On September 13, Research Capital Corporation initiated coverage on Trillion Energy (CSE: TCF) with a...

Thursday, September 15, 2022, 12:37:00 PM

Canaccord Initiates Coverage On Else Nutrition With C$6.50 Price Target

This morning, Canaccord Genuity initiated coverage on Else Nutrition (TSXV: BABY) with a C$6.50 price...

Monday, December 7, 2020, 04:26:00 PM

BBTV Holdings Sees Canaccord Raise Price Target After Financing

Earlier this week, BBTV Holdings (TSX: BBTV) announced that they closed their upsized 7% convertible...

Saturday, June 19, 2021, 05:14:00 PM

Canaccord Cuts Price Target On Meta Platforms To $170

Meta Platforms (Nasdaq: META) last week announced that they would be laying off 11,000 employees...

Thursday, November 17, 2022, 07:26:00 AM

Ayr Wellness: Canaccord Reiterates $70 Price Target Following Earnings

Earlier this week, Ayr Wellness (CSE: AYR.a) reported their first-quarter earnings. The company reported revenues...

Friday, May 28, 2021, 04:02:00 PM